0
0
1/21/23 at 1:57pm
Organization
The Boston Globe
41 words
0
Comments
Biotech acquisitions, funding, public offerings, and stock prices fell in 2022, sending small companies into survival mode — and hoping for an economic turnaround.
You are the first to view
https://www.bostonglobe.com/2023/01/21/business/holding-by-its-fingernails-biotech-industry-braces-another-tough-year/
Create an account
or login to join the discussion